Cargando…
Clinical and economic outcomes of a “high-touch” clinical management program for intravenous immunoglobulin therapy
OBJECTIVE: To compare clinical and economic outcomes of patients who received intravenous immunoglobulin (IVIG) therapies and were managed by a clinical management program vs the outcomes of matched controls using administrative claim data. METHODS: This retrospective cohort study used the PharMetri...
Autores principales: | Zhu, Julia, Kirkham, Heather S, Ayer, Gretchen, Chen, Chi-Chang, Wade, Rolin L, Karkare, Swapna U, Robson, Chester H, Orange, Jordan S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741071/ https://www.ncbi.nlm.nih.gov/pubmed/29296090 http://dx.doi.org/10.2147/CEOR.S142239 |
Ejemplares similares
-
Outcome Evaluation of a Subcutaneous Immunoglobulin Clinical Management Program
por: Zhu, Julia, et al.
Publicado: (2019) -
Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013) -
Therapeutic Use of Immunoglobulins
por: Stiehm, E. Richard, et al.
Publicado: (2010) -
The original sins of clinical trials with intravenous immunoglobulins in sepsis
por: Almansa, Raquel, et al.
Publicado: (2015) -
Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
por: Ritchie, Bruce, et al.
Publicado: (2022)